Table 1 Baseline Characteristics of patients according to designated groups
|  | PACB (n = 118) | PAC (n = 118) | p-value |
|---|---|---|---|
Age (mean, SD) | 60.1 (12.7) | 59.4 (12.4) | 0.693 |
Sex | Â | Â | 0.595 |
 Male (n,%) | 73 (61.9) | 69(58.5) |  |
 Female (n,%) | 45(38.1) | 49 (41.5) |  |
 Body Weight (mean, SD) | 63.9 (10.2) | 63.8 (9.5) | 0.939 |
Smoking | Â | Â | 0.496 |
 Current | 24 (20.3) | 21 (17.9) |  |
 Never | 84 (71.2) | 90 (76.9) |  |
 Ex | 10 (8.5) | 6 (5.1) |  |
Alcohol | Â | Â | 0.024 |
 Current | 53 (44.9) | 34 (29.1) |  |
 Never | 59 (50.0) | 79 (67.5) |  |
 Ex | 6 (5.1) | 4 (3.4) |  |
Comorbidity | |||
 Having one or more comorbidity | 49 (41.5%) | 51 (43.2%) | 0.792 |
 CKD | 1 (0.8%) | 0 | 1.000 |
 DM | 14 (11.9%) | 22 (18.6%) | 0.148 |
 Hypertension | 18 (15.3%) | 18 (15.3%) | 1.000 |
 Dyslipidemia | 21 (17.8%) | 21 (17.8%) | 1.000 |
 Use of aspirin or antiplatelets | 1 (0.8%) | 5 (4.2%) | 0.213 |
 Malignancy of other organs | 2 (1.7%) | 2 (1.7%) | 1.000 |
Reason for H.pylori eradication | Â | Â | 0.300 |
 H.pylori gastritis | 39 (33.1) | 41 (34.7) |  |
 AG-IM | 16 (13.6) | 23 (19.5) |  |
 PUD | 39 (33.1) | 27 (22.9) |  |
 Dysplasia or carcinoma | 24 (20.3) | 27 (22.9) |  |